Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Meijuan Sui, Hong Wei, Xiaohan Shen, Keke Gao, Qian Zhang & Zhuo Zhang. (2023) Sulfhydryl compound levels are associated with ATO-induced side effects in acute promyelocytic leukemia patients. Hematology 28:1.
Read now
Read now
So-Youn Woo, Mi-Young Lee, Yun-Jae Jung, Eun-Sun Yoo, Ju-Young Seoh, Hee-Young Shin, Hyo-Seop Ahn & Kyung-Ha Ryu. (2006) ARSENIC TRIOXIDE INHIBITS CELL GROWTH IN SH-SY5Y AND SK-N-AS NEUROBLASTOMA CELL LINES BY A DIFFERENT MECHANISM. Pediatric Hematology and Oncology 23:3, pages 231-243.
Read now
Read now
Chin-Hsiao Tseng. (2005) Blackfoot Disease and Arsenic: A Never-Ending Story. Journal of Environmental Science and Health, Part C 23:1, pages 55-74.
Read now
Read now
Kyung-Ha Ryu, So-Youn Woo, Mi-Young Lee, Yun-Jae Jung, Eun-Sun Yoo, Ju-Young Seoh, Jeong-Hae Kie, Hee-Young Shin & Hyo-Seop Ahn. (2005) MORPHOLOGICAL AND BIOCHEMICAL CHANGES INDUCED BY ARSENIC TRIOXIDE IN NEUROBLASTOMA CELL LINES. Pediatric Hematology and Oncology 22:7, pages 609-621.
Read now
Read now
Markus Thomas Rojewski, Sixten Körper & Hubert Schrezenmeier. (2004) Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside. Leukemia & Lymphoma 45:12, pages 2387-2401.
Read now
Read now
Ming-Jer Huang, Ruey-Kuen Hsieh, Che-pin Lin, Ian Y Chang & Hsing-Jin Liu. (2002) The Cytotoxicity of Arsenic Trioxide to Normal Hematopoietic Progenitors and Leukemic Cells is Dependent on Their Cell-cycle Status. Leukemia & Lymphoma 43:11, pages 2191-2199.
Read now
Read now
Articles from other publishers (52)
Ning Lv, Chunyan Huang, Haoyan Huang, Zhiqiang Dong, Xijing Chen, Chengcan Lu & Yongjie Zhang. (2023) Overexpression of Glutathione S-Transferases in Human Diseases: Drug Targets and Therapeutic Implications. Antioxidants 12:11, pages 1970.
Crossref
Crossref
Zhuo Zhang, Shunji Zhang, Fan Zhang, Qian Zhang, Hong Wei, Ruolin Xiu, Yanhong Zhao & Meijuan Sui. (2023) Clinical Indicators of Hepatotoxicity in Newly Diagnosed Acute Promyelocytic Leukemia Patients Undergoing Arsenic Trioxide Treatment. Biological Trace Element Research.
Crossref
Crossref
Saranya NavaneethaKrishnan, Jesusa L. Rosales & Ki-Young Lee. 2022. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects
599
618
.
Jing Tang, Chenjuan Yao, Yingqi Liu, Jiaming Yuan, Li Wu, Kazuo Hosoi, Shali Yu, Chunyan Huang, Haiyan Wei & Gang Chen. (2021) Arsenic trioxide induces expression of BCL-2 expression via NF-κB and p38 MAPK signaling pathways in BEAS-2B cells during apoptosis. Ecotoxicology and Environmental Safety 222, pages 112531.
Crossref
Crossref
Saranya NavaneethaKrishnan, Jesusa L. Rosales & Ki-Young Lee. 2020. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects
1
20
.
Xiaoli Hu, Jiayi Cai, Jianyi Zhu, Wenjing Lang, Jihua Zhong, Hua Zhong & Fangyuan Chen. (2020) Arsenic trioxide potentiates Gilteritinib-induced apoptosis in FLT3-ITD positive leukemic cells via IRE1a-JNK-mediated endoplasmic reticulum stress. Cancer Cell International 20:1.
Crossref
Crossref
Md Shiblur Rahaman, Shojiro Yamasaki, Kaniz Fatima Binte Hossain, Toshiyuki Hosokawa, Takeshi Saito & Masaaki Kurasaki. (2020) Effects of curcumin, D-pinitol alone or in combination in cytotoxicity induced by arsenic in PC12 cells. Food and Chemical Toxicology 144, pages 111577.
Crossref
Crossref
Soojong Park, Hyun-Tak Han, Sang-Seok Oh, Dong Hyeok Kim, Jin-Woo Jeong, Ki Won Lee, Minju Kim, Jong Seok Lim, Yong Yeon Cho, Cheol Hwangbo, Jiyun Yoo & Kwang Dong Kim. (2019) NDRG2 Sensitizes Myeloid Leukemia to Arsenic Trioxide via GSK3β–NDRG2–PP2A Complex Formation. Cells 8:5, pages 495.
Crossref
Crossref
Xiaoqin Chi, Renyuan Zhang, Tian Zhao, Xuanqing Gong, Ruixue Wei, Zhenyu Yin, Hongyu Lin, Dan Li, Hong Shan & Jinhao Gao. (2019) Targeted arsenite-loaded magnetic multifunctional nanoparticles for treatment of hepatocellular carcinoma. Nanotechnology 30:17, pages 175101.
Crossref
Crossref
Venkatanaidu Karri, Vikas Kumar, David Ramos, Eliandre Oliveira & Marta Schuhmacher. (2017) Comparative In Vitro Toxicity Evaluation of Heavy Metals (Lead, Cadmium, Arsenic, and Methylmercury) on HT-22 Hippocampal Cell Line. Biological Trace Element Research 184:1, pages 226-239.
Crossref
Crossref
Venkatanaidu Karri, Vikas Kumar, David Ramos, Eliandre Oliveira & Marta Schuhmacher. (2018) An in vitro cytotoxic approach to assess the toxicity of heavy metals and their binary mixtures on hippocampal HT-22 cell line. Toxicology Letters 282, pages 25-36.
Crossref
Crossref
Byul Bo Ra Choi & Gyoo Cheon Kim. (2017) Induction apoptosis and G2/M phase cell cycle arrest by non-thermal plasma in human osteosarcoma MG-63 cell line. Oral Biology Research 41:4, pages 229-235.
Crossref
Crossref
Lorien J. Parker, Alessio Bocedi, David B. Ascher, Jade B. Aitken, Hugh H. Harris, Mario Lo Bello, Giorgio Ricci, Craig J. Morton & Michael W. Parker. (2016) Glutathione transferase P1‐1 as an arsenic drug‐sequestering enzyme. Protein Science 26:2, pages 317-326.
Crossref
Crossref
Caixia Li, Ping Li, Yee Min Tan, Siew Hong Lam, Eric C. Y. Chan & Zhiyuan Gong. (2016) Metabolomic Characterizations of Liver Injury Caused by Acute Arsenic Toxicity in Zebrafish. PLOS ONE 11:3, pages e0151225.
Crossref
Crossref
Marc Beyer, Staffan Vandersee, Ioana Cosagarea, Rachid Touba, Markus Möbs & Chalid Assaf. (2016) The Effects of Arsenic Trioxide in Combination with Retinoic Acids on Cutaneous T-Cell Lymphoma Cell Lines. Skin Pharmacology and Physiology 29:2, pages 63-70.
Crossref
Crossref
J. Christopher States. (2015) Disruption of Mitotic Progression by Arsenic. Biological Trace Element Research 166:1, pages 34-40.
Crossref
Crossref
Yukie Tanaka, Takayuki Komatsu, Hiroko Shigemi, Takahiro Yamauchi & Yutaka Fujii. (2014) BIMELis a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine. BMC Cancer 14:1.
Crossref
Crossref
R Wang, L Xia, J Gabrilove, S Waxman & Y Jing. (2012) Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells. Leukemia 27:2, pages 315-324.
Crossref
Crossref
Miran Jang, Yeonghwan Kim, Hyeran Won, Sangbin Lim, Jyothi K.R, Amarjargal Dashdorj, Yoo Hong Min, Si-Young Kim, Kevan M. Shokat, Joohun Ha & Sung Soo Kim. (2012) Carbonyl Reductase 1 Offers a Novel Therapeutic Target to Enhance Leukemia Treatment by Arsenic Trioxide. Cancer Research 72:16, pages 4214-4224.
Crossref
Crossref
Yoko Hiwatashi, Hiroko Tadokoro, Kayo Henmi, Mariko Arai, Toshikazu Kaise, Sachiko Tanaka & Toshihiko Hirano. (2011)
Antiproliferative and anti-invasive effects of inorganic and organic arsenic compounds on human and murine melanoma cells
in vitro
. Journal of Pharmacy and Pharmacology 63:9, pages 1202-1210.
Crossref
Crossref
Kun‐Yun Yeh, John W.‐C. Chang, Ying‐Ying Li, Cheng‐Hsu Wang & Hung‐Ming Wang. (2010) Tumor growth inhibition of metastatic nasopharyngeal carcinoma cell lines by low dose of arsenic trioxide via alteration of cell cycle progression and induction of apoptosis. Head & Neck 33:5, pages 734-742.
Crossref
Crossref
Gabriella Fabbrocini, Maria Triassi, Maria Chiara Mauriello, Guglielma Torre, Maria Carmela Annunziata, Valerio De Vita, Francesco Pastore, Vincenza D’Arco & Giuseppe Monfrecola. (2010) Epidemiology of Skin Cancer: Role of Some Environmental Factors. Cancers 2:4, pages 1980-1989.
Crossref
Crossref
O. BAIREY, A. VANICHKIN & O. SHPILBERG. (2010) Arsenic‐trioxide‐induced apoptosis of chronic lymphocytic leukemia cells. International Journal of Laboratory Hematology 32:1p1.
Crossref
Crossref
Jung Mi ByunDae Hoon JeongDae Sim LeeJoo Ran KimYoung Nam KimEun Jeong JeongMoon Su SungKyoung Bok LeeKi Tae Kim. (2010) Inhibition of cell growth and apoptosis in CaSki, cervical cancer cell line by arsenic compounds. Korean Journal of Obstetrics and Gynecology 53:7, pages 616.
Crossref
Crossref
Pablo E. Vivas-Mejía, Bulent Ozpolat, Xian Chen & Gabriel Lopez-Berestein. (2009)
Downregulation of the
c-MYC
target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia
. International Journal of Cancer 125:2, pages 264-275.
Crossref
Crossref
Rodrigo Franco, Roberto Sánchez-Olea, Elsa M. Reyes-Reyes & Mihalis I. Panayiotidis. (2009) Environmental toxicity, oxidative stress and apoptosis: Ménage à Trois. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 674:1-2, pages 3-22.
Crossref
Crossref
Kathryn F. Tonissen & Giovanna Di Trapani. (2009) Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy. Molecular Nutrition & Food Research 53:1, pages 87-103.
Crossref
Crossref
Tseng-Hsi Lin, Hsing-Chun Kuo, Fen-Pi Chou & Fung-Jou Lu. (2008) Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. BMC Cancer 8:1.
Crossref
Crossref
Xiaoyan Zhao, Tieming Feng, He Chen, Hongli Shan, Yong Zhang, Yanjie Lu & Baofeng Yang. (2008) Arsenic Trioxide-Induced Apoptosis in H9c2 Cardiomyocytes: Implications in Cardiotoxicity. Basic & Clinical Pharmacology & Toxicology 102:5, pages 419-425.
Crossref
Crossref
Chee-Yin Chai, Ya-Chun Huang, Wen-Chun Hung, Wan-Yi Kang & Wan-Tzu Chen. (2007) Arsenic salts induced autophagic cell death and hypermethylation of DAPK promoter in SV-40 immortalized human uroepithelial cells. Toxicology Letters 173:1, pages 48-56.
Crossref
Crossref
Duo Chen, Rosemarie Chan, Samuel Waxman & Yongkui Jing. (2006) Buthionine Sulfoximine Enhancement of Arsenic Trioxide-Induced Apoptosis in Leukemia and Lymphoma Cells Is Mediated via Activation of c-Jun NH2-Terminal Kinase and Up-regulation of Death Receptors. Cancer Research 66:23, pages 11416-11423.
Crossref
Crossref
E. Agostinelli & N. Seiler. (2006) Non-irradiation-derived reactive oxygen species (ROS) and cancer: therapeutic implications. Amino Acids 31:3, pages 341-355.
Crossref
Crossref
Hyun Sook Jung, Han-Seong Kim, Min-Jae Lee, Hee Young Shin, Hyo Seop Ahn, Kyung-Ha Ryu, Ju-Young Seoh, Chong Jai Kim & Ja June Jang. (2006) Arsenic trioxide concentration determines the fate of Ewing's sarcoma family tumors and neuroblastoma cells in vitro. FEBS Letters 580:20, pages 4969-4975.
Crossref
Crossref
Tomasz M. Beer, Catherine M. Tangen, Craig R. Nichols, Kim A. Margolin, Robert Dreicer, William T. Stephenson, David I. Quinn, Derek Raghavan & E. David Crawford. (2006) Southwest oncology group phase II study of arsenic trioxide in patients with refractory germ cell malignancies. Cancer 106:12, pages 2624-2629.
Crossref
Crossref
Ana-Maria Florea, Ebenezer N. Yamoah & Elke Dopp. (2005) Intracellular Calcium Disturbances Induced by Arsenic and Its Methylated Derivatives in Relation to Genomic Damage and Apoptosis Induction. Environmental Health Perspectives 113:6, pages 659-664.
Crossref
Crossref
Giovanna Tabellini, Alessandra Cappellini, Pier Luigi Tazzari, Federica Falà, Anna Maria Billi, Lucia Manzoli, Lucio Cocco & Alberto M. Martelli. (2005) Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. Journal of Cellular Physiology 202:2, pages 623-634.
Crossref
Crossref
Guo-Qiang Chen, Qiong Wang, Hua Yan & Zhu Chen. 2005. Natural Products. Natural Products
251
272
.
Jie Yang, Hui Li, Yu-Ying Chen, Xiao-Jing Wang, Gui-Ying Shi, Qing-Shen Hu, Xun-Lei Kang, Yang Lu, Xue-Ming Tang, Qiang-Su Guo & Jing Yi. (2004) Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species-mediated dual regulation of apoptosis. Free Radical Biology and Medicine 37:12, pages 2027-2041.
Crossref
Crossref
Andrew M Evens, Martin S Tallman & Ronald B Gartenhaus. (2004) The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future. Leukemia Research 28:9, pages 891-900.
Crossref
Crossref
Simrit Parmar, Lynn M Rundhaugen, Larry Boehlke, MaryBeth Riley, Chadi Nabhan, Adekunle Raji, John L Frater & Martin S Tallman. (2004) Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old. Leukemia Research 28:9, pages 909-919.
Crossref
Crossref
Jing Yi, Jie Yang, Rong He, Fei Gao, Hairong Sang, Xueming Tang & Richard D. Ye. (2004) Emodin Enhances Arsenic Trioxide-Induced Apoptosis via Generation of Reactive Oxygen Species and Inhibition of Survival Signaling. Cancer Research 64:1, pages 108-116.
Crossref
Crossref
Sanda SturlanMelanie BaumgartnerErich RothThomas Bachleitner-Hofmann. (2003) Docosahexaenoic acid enhances arsenic trioxide–mediated apoptosis in arsenic trioxide–resistant HL-60 cells. Blood 101:12, pages 4990-4997.
Crossref
Crossref
Chin-Hsiao Tseng. (2016) An Overview on Peripheral Vascular Disease in Blackfoot Disease-Hyperendemic Villages in Taiwan. Angiology 53:5, pages 529-537.
Crossref
Crossref
Wilson H. MillerJr.Jr.. (2002) Molecular Targets of Arsenic Trioxide in Malignant Cells. The Oncologist 7:S1, pages 14-19.
Crossref
Crossref
James L. Slack, Samuel Waxman, Guido Tricot, Martin S. Tallman & Clara D. Bloomfield. (2002) Advances in the Management of Acute Promyelocytic Leukemia and Other Hematologic Malignancies with Arsenic Trioxide. The Oncologist 7:S1, pages 1-13.
Crossref
Crossref
Ann M. Bode & Zigang Dong. (2002) The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Critical Reviews in Oncology/Hematology 42:1, pages 5-24.
Crossref
Crossref
Ying Deng, Huibi Xu, Kaixun Huang, Xiangliang Yang, Changsheng Xie & Juan Wu. (2001) Size effects of realgar particles on apoptosis in a human umbilical vein endothelial cell line: ECV-304. Pharmacological Research 44:6, pages 513-518.
Crossref
Crossref
Claude Boudène. (2001) sur le risque sanitaire lié à la présence d’arsenic dans l’eau minérale naturelle alimentant les établissements thermaux selon la concentration en arsenic de l’eau et l’orientation thérapeutique pratiquée. Bulletin de l'Académie Nationale de Médecine 185:8, pages 1587-1599.
Crossref
Crossref
M.S. Tallman. (2001) Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies. Blood Reviews 15:3, pages 133-142.
Crossref
Crossref
Mark L. Bernstein, Gregory H. Reaman & Steven Hirschfeld. (2001) DEVELOPMENTAL THERAPEUTICS IN CHILDHOOD CANCER. Hematology/Oncology Clinics of North America 15:4, pages 631-655.
Crossref
Crossref
W. Tarello. (2001) Chronic Fatigue Syndrome (CFS) in 15 dogs and cats with specific biochemical and microbiological anomalies. Comparative Immunology, Microbiology and Infectious Diseases 24:3, pages 165-185.
Crossref
Crossref
Fei Chen, Yongju Lu, Zhuo Zhang, Val Vallyathan, Min Ding, Vince Castranova & Xianglin Shi. (2001) Opposite Effect of NF-κB and c-Jun N-terminal Kinase on p53-independent GADD45 Induction by Arsenite. Journal of Biological Chemistry 276:14, pages 11414-11419.
Crossref
Crossref